CAMBRIDGE, Mass., March 31, 2011 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat severe lipid disorders, announced today that it will participate in the 10th Annual Needham Healthcare Conference in New York City. Marc Beer, CEO of Aegerion, is scheduled to present on Tuesday, April 5, 2011, at 10:40 a.m. ET.
